BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024
BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products for cell and gene therapies and biopharma markets, has scheduled its third quarter 2024 financial results release for November 12, 2024, after market close. The company will host a conference call and webcast at 4:30pm ET to discuss financial results and provide a business update. Investors can access the webcast through BioLife's website, or join via phone using toll-free numbers. A replay will be available for 90 days on the company's investor relations page.
BioLife Solutions (NASDAQ: BLFS), un importante sviluppatore e fornitore di prodotti per bioproduzione destinati alle terapie cellulari, geniche e ai mercati biopharma, ha programmato la pubblicazione dei suoi risultati finanziari del terzo trimestre 2024 per il 12 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast alle 16:30 ET per discutere i risultati finanziari e fornire un aggiornamento aziendale. Gli investitori possono accedere al webcast tramite il sito web di BioLife o partecipare telefonicamente utilizzando numeri verdi. Una registrazione sarà disponibile per 90 giorni sulla pagina delle relazioni con gli investitori dell'azienda.
BioLife Solutions (NASDAQ: BLFS), un desarrollador y proveedor líder de productos de bioproducción para terapias celulares, génicas y mercados biopharma, ha programado la publicación de sus resultados financieros del tercer trimestre de 2024 para el 12 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica y un webcast a las 4:30 p.m. ET para discutir los resultados financieros y proporcionar una actualización del negocio. Los inversores pueden acceder al webcast a través del sitio web de BioLife, o unirse por teléfono utilizando números de acceso gratuito. Una repetición estará disponible durante 90 días en la página de relaciones con inversores de la empresa.
BioLife Solutions (NASDAQ: BLFS)는 세포 및 유전자 요법과 생물 의약품 시장을 위한 바이오 생산 제품의 주요 개발자이자 공급업체로, 2024년 3분기 재무 결과 발표를 2024년 11월 12일, 시장 종료 후로 예정하고 있습니다. 회사는 4:30 PM ET에 재무 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 전화 회의 및 웹 캐스트를 개최합니다. 투자자들은 BioLife의 웹사이트를 통해 웹 캐스트에 접속하거나 무료 전화 번호를 사용하여 참여할 수 있습니다. 회사의 투자자 관계 페이지에서는 90일 동안 재생할 수 있습니다.
BioLife Solutions (NASDAQ: BLFS), un développeur et fournisseur de premier plan de produits de bioproduction pour les thérapies cellulaires et géniques ainsi que pour les marchés biopharmaceutiques, a programmé la publication de ses résultats financiers du troisième trimestre 2024 pour le 12 novembre 2024, après la clôture du marché. L'entreprise organisera une conférence téléphonique et un webcast à 16h30 ET pour discuter des résultats financiers et fournir une mise à jour sur l'entreprise. Les investisseurs peuvent accéder au webcast via le site Web de BioLife ou participer par téléphone en utilisant des numéros gratuits. Un enregistrement sera disponible pendant 90 jours sur la page des relations investisseurs de l'entreprise.
BioLife Solutions (NASDAQ: BLFS), ein führender Entwickler und Anbieter von Bioproduktionsprodukten für Zell- und Gentherapien sowie den Biopharmamarkt, hat die Veröffentlichung seiner finanziellen Ergebnisse für das dritte Quartal 2024 für den 12. November 2024 nach Marktschluss angesetzt. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast veranstalten, um die finanziellen Ergebnisse zu diskutieren und ein Update zur Geschäftslage zu geben. Investoren können über die Website von BioLife auf das Webcast zugreifen oder sich telefonisch über gebührenfreie Nummern einwählen. Eine Wiederholung wird für 90 Tage auf der Investor Relations-Seite des Unternehmens verfügbar sein.
- None.
- None.
To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-third-quarter-2024-financial-results-and-business-update-on-november-12-2024-302293378.html
SOURCE BioLife Solutions, Inc.
FAQ
When will BioLife Solutions (BLFS) release Q3 2024 earnings?
What time is BioLife Solutions (BLFS) Q3 2024 earnings call?
How can I access BioLife Solutions (BLFS) Q3 2024 earnings call?
